NASDAQ:BJDX | Free Cash Flow | Bluejay Diagnostics, Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$1.59M$18,989.00-$1.61M
2025-12-31-$1.45M
2025-03-31-$1.18M
2024-12-31-$1.45M$1,125.00-$1.45M
2024-03-31-$2.3M$35,433.00-$2.34M
2023-12-31-$2.78M$87,894.00-$2.87M
2023-03-31-$2.93M$340,669.00-$3.27M
2022-12-31-$2.94M$238,207.00-$3.18M
2022-03-31-$1.88M$46,346.00-$1.92M
2021-12-31-$2.52M$17,733.00-$2.54M
2021-03-31-$372,620.00
2020-12-31-$154,856.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$6.05M$173,735.00-$6.23M
2024-12-31-$7.82M$306,783.00-$8.13M
2023-12-31-$8.31M$704,166.00-$9.02M
2022-12-31-$7.74M$1.2M-$8.94M
2021-12-31-$4.37M$23,947.00-$4.39M
2020-12-31-$508,710.00